Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Stern

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
British Journal of Clinical Pharmacology|October 1, 1986
The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuationsR J Hardie, S L Malcolm, A J Lees, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1989
The effects of oral protein on the absorption of intraduodenal levodopa and motor performanceJ P Frankel, P A Kempster, M Bovingdon, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 23, 2001
Cultured human foetal cerebral cortex, transfected with tyrosine hydroxylase cDNA, as a source of neural transplant materialM J Hurley, D J Gerard, E Jauniaux, et al.
Journal of Neural Transmission|January 1, 1978
Endocrine aspects of bromocriptine therapy in ParkinsonismK M Shaw, A J Lees, S Franks, et al.
British Journal of Clinical Pharmacology|December 1, 1978
Deprenyl is metabolized to methamphetamine and amphetamine in manG P Reynolds, J D Elsworth, K Blau, et al.
Brain Research|December 16, 1996
The depolarisation-induced release of [125I]BDNF from brain tissueA Androutsellis-Theotokis, W J McCormack, H F Bradford, et al.
Lancet (London, England)|September 16, 1972
Metatyrosine in the treatment of parkinsonismM Sandler, S J Corne, R Stephens, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's diseaseP A Kempster, J P Frankel, M Bovingdon, et al.
Lancet (London, England)|January 24, 1976
Letter: Growth-hormone response to bromocriptine in parkinsonismK M Shaw, A J Lees, S Hayes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five yearsA J Hughes, S Bishop, B Kleedorfer, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|October 1, 1986
The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuationsR J Hardie, S L Malcolm, A J Lees, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1989
The effects of oral protein on the absorption of intraduodenal levodopa and motor performanceJ P Frankel, P A Kempster, M Bovingdon, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 23, 2001
Cultured human foetal cerebral cortex, transfected with tyrosine hydroxylase cDNA, as a source of neural transplant materialM J Hurley, D J Gerard, E Jauniaux, et al.
Journal of Neural Transmission|January 1, 1978
Endocrine aspects of bromocriptine therapy in ParkinsonismK M Shaw, A J Lees, S Franks, et al.
British Journal of Clinical Pharmacology|December 1, 1978
Deprenyl is metabolized to methamphetamine and amphetamine in manG P Reynolds, J D Elsworth, K Blau, et al.
Brain Research|December 16, 1996
The depolarisation-induced release of [125I]BDNF from brain tissueA Androutsellis-Theotokis, W J McCormack, H F Bradford, et al.
Lancet (London, England)|September 16, 1972
Metatyrosine in the treatment of parkinsonismM Sandler, S J Corne, R Stephens, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's diseaseP A Kempster, J P Frankel, M Bovingdon, et al.
Lancet (London, England)|January 24, 1976
Letter: Growth-hormone response to bromocriptine in parkinsonismK M Shaw, A J Lees, S Hayes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five yearsA J Hughes, S Bishop, B Kleedorfer, et al.
Pageof 14